Phase 3 Severe Asthma Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma
Moderate to Severe Asthma
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.230 enrolled1 locationNCT07372287
Recruiting
Phase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Severe Asthma
Generate Biomedicines786 enrolled27 locationsNCT07276724
Recruiting
Phase 3
Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
Severe Asthma
AstraZeneca400 enrolled76 locationsNCT07363642
Recruiting
Phase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Severe Asthma
Generate Biomedicines786 enrolled11 locationsNCT07359846
Recruiting
Phase 2Phase 3
A Study of CM310 in Subjects With Moderate to Severe Asthma
Moderate to Severe Asthma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.600 enrolled1 locationNCT05761028